Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 National Biotechnology Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Allababidi, Saleh
LAPIX Therapeutics Inc.
(
T1030-01-03
)
Tolerization with a Novel Tim Agonist Dual-Acting Liposomal Formulation Prepares the Immune System for the Success of Gene Therapy
Saleh Allababidi
Favorite
Amara, Celine
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Celine Amara
Favorite
Avery, Lindsay
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Lindsay Avery
Favorite
B
Bagwe, Priyal
Mercer University
(
M1130-01-01
)
An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice
Priyal Bagwe
Favorite
Balu-Iyer, Sathy
University at Buffalo
(
T1330-01-03
)
Harnessing Dendritic Cell Migration as a Predictor of Subcutaneous Immunogenicity Risk in a Mechanism-Based Screening Tool
Sathy Balu-Iyer
Favorite
Barthel, Ben
Edgewise Therapeutics
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Ben Barthel
Favorite
Beams, Ashley
Navigate BioPharma Services, Inc.
(
T1330-01-08
)
Multiplexed Quantification of CAR-T Subtypes by PCR
Ashley Beams
Favorite
Berger, Scott
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Scott Berger
Favorite
Bigos, Pawel
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Pawel Bigos
Favorite
Birdsall, Robert
Waters Corporation
(
M1030-01-02
)
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Robert Birdsall
Favorite
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Robert Birdsall
Favorite
Bitsaktsis, Constantine
Novartis Institutes for BioMedical Research
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Constantine Bitsaktsis
Favorite
Blackmer, Rachel
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Rachel Blackmer
Favorite
Bower, Brian
BioAgilytix Labs
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Brian Bower
Favorite
Bowsher, Ron
B2S Life Sciences
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Ron Bowsher
Favorite
Brenner, Jacob
University of Pennsylvania
(
T1030-01-08
)
Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
Jacob Brenner
Favorite
Brinson, Robert
National Institute of Standards and Technology
(
M1130-01-06
)
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
Robert Brinson
Favorite
Brown, Larry
Noveome Biotherapeutics, Inc.
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Larry Brown
Favorite
Buanafina, Fernanda
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Fernanda Buanafina
Favorite
C
Carnovale, Miriam
IFF
(
M1330-01-03
)
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Miriam Carnovale
Favorite
Catalano, Al
BioAgilytix Labs, LLC.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Al Catalano
Favorite
Chaly, Yury
Bristol-Myers Squibb Company
(
T1330-01-02
)
Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
Yury Chaly
Favorite
Chappell, John
Gyros Protein Technologies
(
M1030-01-01
)
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
John Chappell
Favorite
(
T1130-01-01
)
Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
John Chappell
Favorite
Chase, Liam
University of Pennsylvania
(
T1030-01-08
)
Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
Liam Chase
Favorite
Cheng, Sau Wan
Chinese University of Hong Kong
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Sau Wan Cheng
Favorite
Chen, Hong
Alliance Pharma Inc.
(
M1130-01-08
)
Establishment of a Generic ADA Assay for Detection of Anti-Drug Antibody Specific to Human IgG Derived Drug Candidate in Murine Serum Samples
Hong Chen
Favorite
(
T1130-01-08
)
Labelling AAV5 Capsid Reduced Its Binding Affinity to the Anti-AAV5 Antibody in Non-primate Human Serum Samples
Hong Chen
Favorite
(
T1430-01-04
)
A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Hong Chen
Favorite
Chen, Ming-Luan
Altasciences
(
M1330-01-05
)
Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
Ming-Luan Chen
Favorite
Coddington, Ashley
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Ashley Coddington
Favorite
Cookson, Colt
Veloxity Labs, LLC
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Colt Cookson
Favorite
Corpstein, Clairissa D.
Purdue University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Clairissa D. Corpstein
Favorite
Craig, Caryn
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Caryn Craig
Favorite
Craig, Jane
Labcorp Drug Development
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Jane Craig
Favorite
Creamer, Luke
Alliance Pharma Inc.
(
T1430-01-04
)
A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Luke Creamer
Favorite
Cross, Abigail
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Abigail Cross
Favorite
Crowe, Molly
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Molly Crowe
Favorite
Czepczor, Valerie
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Valerie Czepczor
Favorite
D
Davletov, Bazbek
Neuresta
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Bazbek Davletov
Favorite
DeBrabandere, Veronique
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Veronique DeBrabandere
Favorite
DeGroot, Anne
EpiVax Inc.
(
M1030-01-04
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Anne DeGroot
Favorite
(
M1130-01-05
)
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Anne DeGroot
Favorite
DeLaney, Kellen
Waters Corporation
(
M1030-01-02
)
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Kellen DeLaney
Favorite
Dellatore, Shara
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Shara Dellatore
Favorite
Di, Jiaxing
Purdue University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Jiaxing Di
Favorite
D'Souza, Martin
Mercer University
(
M1130-01-01
)
An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice
Martin D'Souza
Favorite
Dube, Namita
Rensselaer Polytechnic Institute
(
T1030-01-09
)
Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
Namita Dube
Favorite
Dutt, Muskaan
Altasciences
(
M1330-01-05
)
Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
Muskaan Dutt
Favorite
E
Eaglen, Kathryn
Labcorp
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Kathryn Eaglen
Favorite
Eckerston, Ann
Gyros Protein Technologies
(
M1030-01-01
)
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
Ann Eckerston
Favorite
F
Faden, Edward
MAC-MOD Analytical
(
M1030-01-03
)
Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography
Edward Faden
Favorite
(
M1430-01-02
)
Approaches for Reducing the Environmental Impact and Increasing the Throughput of Bioanalytical LC Separations
Edward Faden
Favorite
Faden, Geoff
MAC-MOD Analytical
(
M1030-01-03
)
Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography
Geoff Faden
Favorite
Faden, Geoffrey
MAC-MOD Analytical
(
M1430-01-02
)
Approaches for Reducing the Environmental Impact and Increasing the Throughput of Bioanalytical LC Separations
Geoffrey Faden
Favorite
Fares, Hadi
IFF
(
M1330-01-03
)
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Hadi Fares
Favorite
(
T1430-01-01
)
Alginate Hydrogels: A Tunable Tool for Biotech Applications
Hadi Fares
Favorite
Fathallah, Anas
LAPIX Therapeutics Inc.
(
M1130-01-04
)
XenoImmuneâ„¢ Mouse Model, a Novel and Proprietary Animal Model that Recapitulates Clinical Immunogenicity Rates of Biologics
Anas Fathallah
Favorite
(
T1030-01-03
)
Tolerization with a Novel Tim Agonist Dual-Acting Liposomal Formulation Prepares the Immune System for the Success of Gene Therapy
Anas Fathallah
Favorite
Fischer, Leyla
BioNTech SE
(
M1330-01-01
)
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
Leyla Fischer
Favorite
Flye, Leanne
Labcorp
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Leanne Flye
Favorite
Flynn, Joe
Veloxity Labs, LLC
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Joe Flynn
Favorite
Forsström, Daniel
Gyros Protein Technologies
(
M1330-01-01
)
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
Daniel Forsström
Favorite
Fox, Chris
Gyros Protein Technologies
(
M1330-01-01
)
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
Chris Fox
Favorite
Friedman, Tatyana
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Tatyana Friedman
Favorite
Fulton, William
Johns Hopkins University
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
William Fulton
Favorite
G
Gadkari, Snaehal
Bristol-Myers Squibb Company
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Snaehal Gadkari
Favorite
Gatewood, James
Evonik
(
T1430-01-02
)
Preparation of PEG-b-PLA Nanoparticles via Inline Sonication for Controlled Release Applications
James Gatewood
Favorite
Gayakwad, Sanjaykumar
Massachusetts College of Pharmacy and Health Science
(
M1130-01-09
)
Development of an In Vitro Cell Culture Model for Evaluation of Influenza Vaccine Formulated Using Spray-Dried Albumin Nanoparticles
Sanjaykumar Gayakwad
Favorite
Gehman, Andrew
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Andrew Gehman
Favorite
Goodyear, Andrew
NGM Biopharmaceuticals
(
M1430-01-03
)
Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
Andrew Goodyear
Favorite
Gray, Ann
Waters Corporation
(
M1030-01-02
)
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Ann Gray
Favorite
Gualano, Virginie
Phinc Development
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Virginie Gualano
Favorite
Gullick, Bryan
BioAgilytix Labs, LLC.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Bryan Gullick
Favorite
Gu, Mianzhi
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Mianzhi Gu
Favorite
Gupta, Paridhi
University of Tennessee Health Science Center
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Paridhi Gupta
Favorite
H
Hackam, David
Johns Hopkins University
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
David Hackam
Favorite
Haltaufderhyde, Kirk
EpiVax Inc.
(
M1030-01-04
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Kirk Haltaufderhyde
Favorite
Han, Duanduan
Waters Corporation
(
M1030-01-02
)
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Duanduan Han
Favorite
Hara, Hisanori
Novartis Institutes for BioMedical Research
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Hisanori Hara
Favorite
Hauther, Christine
Labcorp
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Christine Hauther
Favorite
Hays, Amanda
BioAgilytix Labs, LLC.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Amanda Hays
Favorite
Heisey, Daniel
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Daniel Heisey
Favorite
Hendrix, Eiron
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Eiron Hendrix
Favorite
Hoke, Nicholas
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Nicholas Hoke
Favorite
Hou, Peng
Purdue University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Peng Hou
Favorite
Huang, Catherine
Genentech, Inc.
(
M1030-01-06
)
Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study
Catherine Huang
Favorite
Humphreys, Sara
Amgen Inc.
(
M1330-01-04
)
High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
Sara Humphreys
Favorite
Hwang, Sung-joo
Yonsei University
(
T1330-01-04
)
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Sung-joo Hwang
Favorite
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Sung-joo Hwang
Favorite
I
Ichetovkin, Marina
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Marina Ichetovkin
Favorite
Imperatore, Joshua
National Institute of Standards and Technology
(
M1130-01-06
)
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
Joshua Imperatore
Favorite
Iwuagwu, Justin
Amgen Inc.
(
M1330-01-04
)
High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
Justin Iwuagwu
Favorite
J
Jain, Tushar
Adimab
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Tushar Jain
Favorite
Jainul Abdeen, Sanofar
B2S Life Sciences
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Sanofar Jainul Abdeen
Favorite
James, Matt
Avantor
(
M1430-01-02
)
Approaches for Reducing the Environmental Impact and Increasing the Throughput of Bioanalytical LC Separations
Matt James
Favorite
Jarvi, Nicole
University at Buffalo
(
T1330-01-03
)
Harnessing Dendritic Cell Migration as a Predictor of Subcutaneous Immunogenicity Risk in a Mechanism-Based Screening Tool
Nicole Jarvi
Favorite
Jawa, Vibha
Bristol-Myers Squibb Company
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Vibha Jawa
Favorite
(
T1330-01-02
)
Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
Vibha Jawa
Favorite
Jeong, Jaekwan
Yonsei University
(
T1330-01-04
)
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Jaekwan Jeong
Favorite
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Jaekwan Jeong
Favorite
Jih, Gloria
Century Therapeutics, Inc.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Gloria Jih
Favorite
Jimenez, Luis
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Luis Jimenez
Favorite
Johnson, Ashton
Labcorp
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Ashton Johnson
Favorite
Johnson, Cristina
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Cristina Johnson
Favorite
Johnson, Derrick
B2S Life Sciences
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Derrick Johnson
Favorite
Johnson, Mitch
Veloxity Labs, LLC
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Mitch Johnson
Favorite
Jordan, Susan
IFF
(
M1330-01-03
)
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Susan Jordan
Favorite
Jung, David
Evonik Canada Inc.
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
David Jung
Favorite
K
Kamble, Nitin
University of Cincinnati
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Nitin Kamble
Favorite
Kasinath, Aparna
Syngene International Ltd.
(
M1430-01-08
)
Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
Aparna Kasinath
Favorite
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Aparna Kasinath
Favorite
Katz, Joshua
IFF
(
M1330-01-03
)
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Joshua Katz
Favorite
(
T1430-01-01
)
Alginate Hydrogels: A Tunable Tool for Biotech Applications
Joshua Katz
Favorite
Keasey, Nikki
Alliance Pharma Inc.
(
T1430-01-04
)
A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Nikki Keasey
Favorite
Kelly, Sam
Century Therapeutics, Inc.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Sam Kelly
Favorite
Keyhani, Anahita
Altasciences
(
M1330-01-05
)
Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
Anahita Keyhani
Favorite
Khraisat, Rama
Yonsei University
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Rama Khraisat
Favorite
Kiesler, Kevin
National Institute of Standards and Technology
(
M1130-01-06
)
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
Kevin Kiesler
Favorite
Kim, Bumjun
Princeton University
(
T1130-01-06
)
Development and Optimization of Next-Generation Lipid Nanoparticles for In Situ CAR-T Production
Bumjun Kim
Favorite
Kim, Daniel
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Daniel Kim
Favorite
Kim, Haneul
Yonsei University
(
T1330-01-04
)
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Haneul Kim
Favorite
Kim, Johan
NGM Biopharmaceuticals
(
M1430-01-03
)
Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
Johan Kim
Favorite
Kizekai, Lavelay
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Lavelay Kizekai
Favorite
Klauss, Linda
Gyros Protein Technologies
(
M1030-01-01
)
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
Linda Klauss
Favorite
Klieber, Sylvie
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Sylvie Klieber
Favorite
Koch, Sheryl
University of Cincinnati College of Medicine
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Sheryl Koch
Favorite
Kotagiri, Nalinikanth
University of Cincinnati College of Pharmacy
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Nalinikanth Kotagiri
Favorite
Kozhich, Alexander
Bristol-Myers Squibb Company
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Alexander Kozhich
Favorite
(
T1330-01-02
)
Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
Alexander Kozhich
Favorite
Krick, Alain
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Alain Krick
Favorite
Kumar, Mahesh
Syngene International Ltd.
(
M1430-01-08
)
Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
Mahesh Kumar
Favorite
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Mahesh Kumar
Favorite
Kwok, Rosanna
Genentech, Inc.
(
M1030-01-06
)
Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study
Rosanna Kwok
Favorite
L
Löthberg, Frida
Gyros Protein Technologies
(
T1130-01-01
)
Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
Frida Löthberg
Favorite
Lackey, Alan
Labcorp
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Alan Lackey
Favorite
Lacovara, Maria
PPD Laboratories
(
M1430-01-01
)
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Maria Lacovara
Favorite
Lakshminarasimhan, Mahadevan (Maha)
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Mahadevan (Maha) Lakshminarasimhan
Favorite
Lam, Bao
Alliance Pharma USA
(
M1130-01-08
)
Establishment of a Generic ADA Assay for Detection of Anti-Drug Antibody Specific to Human IgG Derived Drug Candidate in Murine Serum Samples
Bao Lam
Favorite
Lamptey, Richard
North Dakota State University
(
M1430-01-04
)
Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
Richard Lamptey
Favorite
Lauber, Matthew
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Matthew Lauber
Favorite
Lavelle, Amy
PPD Laboratories
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Amy Lavelle
Favorite
Le Merdy, Maxime
Simulations Plus, Inc.
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Maxime Le Merdy
Favorite
Lee, Jongju
Yonsei University
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Jongju Lee
Favorite
Lee, Juseung
Yonsei University
(
T1330-01-04
)
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Juseung Lee
Favorite
Lee, Kevin
Navigate Biopharma Services, Inc., a Novartis subsidiary
(
T1330-01-08
)
Multiplexed Quantification of CAR-T Subtypes by PCR
Kevin Lee
Favorite
Levy, Ronald
Stanford University
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Ronald Levy
Favorite
Li, Betty
NGM Biopharmaceuticals
(
M1430-01-03
)
Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
Betty Li
Favorite
Linh, Dinh Khanh
Yonsei University
(
T1330-01-04
)
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Dinh Khanh Linh
Favorite
Li, Tonglei
Purdue University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Tonglei Li
Favorite
Liu, Fei
Evonik
(
T1430-01-02
)
Preparation of PEG-b-PLA Nanoparticles via Inline Sonication for Controlled Release Applications
Fei Liu
Favorite
Li, Zihui
Amgen Inc.
(
M1330-01-04
)
High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
Zihui Li
Favorite
Lochmann, Timothy
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Timothy Lochmann
Favorite
Longacre, Bryanna
KCAS Bioanalytical & Biomarker
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Bryanna Longacre
Favorite
Lopez-Lee, Nena
Gyros Protein Technologies
(
M1030-01-01
)
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
Nena Lopez-Lee
Favorite
Lorenz, John
University of Cincinnati College of Medicine
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
John Lorenz
Favorite
Lukacova, Viera
Simulations Plus, Inc.
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Viera Lukacova
Favorite
M
Madaan, Tushar
University of Cincinnati
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Tushar Madaan
Favorite
Madden, Molly
Edgewise Therapeutics
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Molly Madden
Favorite
Malz, Alexandra
BioNTech SE
(
M1330-01-01
)
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
Alexandra Malz
Favorite
Maniar, Amudhan
Syngene International Ltd.
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Amudhan Maniar
Favorite
Marino, John
National Institute of Standards and Technology
(
M1130-01-06
)
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
John Marino
Favorite
Marker, Alex
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Alex Marker
Favorite
Martin, William
EpiVax Inc.
(
M1030-01-04
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
William Martin
Favorite
(
M1130-01-05
)
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
William Martin
Favorite
Mavroudis, Panteleimon
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Panteleimon Mavroudis
Favorite
Maximov, Anton
Neuresta
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Anton Maximov
Favorite
Mayer, Andrew
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Andrew Mayer
Favorite
Meibohm, Bernd
University of Tennessee Health Science Center
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Bernd Meibohm
Favorite
Mekhssian, Kevork
Altasciences
(
M1330-01-05
)
Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
Kevork Mekhssian
Favorite
Merchant, Zahra
Evonik Canada Inc.
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Zahra Merchant
Favorite
Michel, Alexander
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Alexander Michel
Favorite
Montelione, Gaetano
Rensselaer Polytechnic Institute
(
T1030-01-09
)
Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
Gaetano Montelione
Favorite
Moreno, Zachary
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Zachary Moreno
Favorite
N
Naresh Metha, Vaibhav
Altasciences
(
T1130-01-07
)
Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Vaibhav Naresh Metha
Favorite
Needham, Shane
Veloxity Labs, LLC
(
M1430-01-05
)
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Shane Needham
Favorite
Nelson, Robert
Labcorp
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Robert Nelson
Favorite
Nieman, Michelle
University of Cincinnati College of Medicine
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Michelle Nieman
Favorite
Nifong, Brady
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Brady Nifong
Favorite
O
Omo-Lamai, Serena
University of Pennsylvania
(
T1430-01-05
)
Mechanistic Investigation of Side-Effects of Lung Tropic Lipid Nanoparticles
Serena Omo-Lamai
Favorite
Ortiz, Jessica
Moderna Therapeutics
(
M1430-01-06
)
Bridging of a Duplex to Singleplex bDNA Method to Quantitate mRNA from LNP-mRNA-ABC in Human Serum
Jessica Ortiz
Favorite
P
Park, Juhyun
Yonsei University
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Juhyun Park
Favorite
Park, Junwoo
Yonsei University
(
T1330-01-07
)
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Junwoo Park
Favorite
Parsekhian, Vasken
Altasciences
(
T1130-01-07
)
Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Vasken Parsekhian
Favorite
Patel, Jennifer
Moderna Therapeutics
(
M1430-01-06
)
Bridging of a Duplex to Singleplex bDNA Method to Quantitate mRNA from LNP-mRNA-ABC in Human Serum
Jennifer Patel
Favorite
Pavon, Jorge
Merck Research Laboratories
(
T1430-01-06
)
Multiple Root Causes Impact Methionine Oxidation in a Coformulated Drug Product
Jorge Pavon
Favorite
Pechtl, Isabell
Agilent Technologies Deutschland GmbH
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Isabell Pechtl
Favorite
Peng, Kate
Genentech, Inc.
(
M1030-01-06
)
Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study
Kate Peng
Favorite
Pennington, Matthew
KCAS Bioanalytical & Biomarker
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Matthew Pennington
Favorite
Pennucci, Jason
Moderna Therapeutics
(
M1430-01-06
)
Bridging of a Duplex to Singleplex bDNA Method to Quantitate mRNA from LNP-mRNA-ABC in Human Serum
Jason Pennucci
Favorite
Peretz, Yoav
Labcorp
(
M1330-01-02
)
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Yoav Peretz
Favorite
Perrier, Jérémy
Phinc Development
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Jérémy Perrier
Favorite
Pihlblad, Alma
Gyros Protein Technologies
(
T1030-01-01
)
Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
Alma Pihlblad
Favorite
Pocernich, Chava
Agilent Technologies, Inc.
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Chava Pocernich
Favorite
Polsky, Rodd
GSK plc
(
M1330-01-07
)
A Translational Approach for Measuring Bi-specific Anti-Drug Antibodies in Non-Clinical Studies Using a Drug Tolerant Generic Plug and Play Format
Rodd Polsky
Favorite
Presley, Analise
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Analise Presley
Favorite
Prinz, Bianka
Adimab
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Bianka Prinz
Favorite
Prud'homme, Robert
Princeton University
(
T1130-01-06
)
Development and Optimization of Next-Generation Lipid Nanoparticles for In Situ CAR-T Production
Robert Prud'homme
Favorite
R
Ramachandran, Indu
Century Therapeutics, Inc.
(
T1130-01-02
)
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Indu Ramachandran
Favorite
Ramadan, Abdulraouf
LAPIX Therapeutics Inc.
(
M1130-01-04
)
XenoImmuneâ„¢ Mouse Model, a Novel and Proprietary Animal Model that Recapitulates Clinical Immunogenicity Rates of Biologics
Abdulraouf Ramadan
Favorite
(
T1030-01-03
)
Tolerization with a Novel Tim Agonist Dual-Acting Liposomal Formulation Prepares the Immune System for the Success of Gene Therapy
Abdulraouf Ramadan
Favorite
Rane, Sayali
Massachusetts College of Pharmacy and Health Sciences
(
M1130-01-09
)
Development of an In Vitro Cell Culture Model for Evaluation of Influenza Vaccine Formulated Using Spray-Dried Albumin Nanoparticles
Sayali Rane
Favorite
Riccitelli, Nathan
Navigate BioPharma Services, Inc.
(
T1330-01-08
)
Multiplexed Quantification of CAR-T Subtypes by PCR
Nathan Riccitelli
Favorite
Roadcap, Brad
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Brad Roadcap
Favorite
Roberts, Brian
EpiVax Inc.
(
M1030-01-04
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Brian Roberts
Favorite
Rosenberg, Amy
EpiVax Inc.
(
M1130-01-05
)
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Amy Rosenberg
Favorite
Ryman, Josiah
Merck & Co., Inc.
(
T1030-01-04
)
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Josiah Ryman
Favorite
S
Sadayappan, Sakthivel
University of Cincinnati College of Medicine
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Sakthivel Sadayappan
Favorite
Salha, Danielle
Altasciences
(
T1130-01-07
)
Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Danielle Salha
Favorite
Schiller, James
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
James Schiller
Favorite
Schindele, Patrick
Agilent Technologies Deutschland GmbH
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Patrick Schindele
Favorite
Schwemler, Timothy
Alliance Pharma Inc.
(
M1030-01-08
)
Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
Timothy Schwemler
Favorite
Serafini, Sergio
Novartis Institutes for BioMedical Research
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Sergio Serafini
Favorite
Seshadri, Soorya
EpiVax Inc.
(
M1130-01-05
)
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Soorya Seshadri
Favorite
Shaghaghi, Hoora
Alliance Pharma Inc.
(
M1030-01-08
)
Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
Hoora Shaghaghi
Favorite
Sharkey, James
Gyros Protein Technologies
(
M1030-01-01
)
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
James Sharkey
Favorite
(
M1330-01-01
)
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
James Sharkey
Favorite
(
T1030-01-01
)
Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
James Sharkey
Favorite
(
T1130-01-01
)
Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
James Sharkey
Favorite
Shaw, Pang Chui
Chinese University of Hong Kong
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Pang Chui Shaw
Favorite
Shen, Christina
Amgen Inc.
(
M1330-01-04
)
High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
Christina Shen
Favorite
Shiner, Steve
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Steve Shiner
Favorite
Shyr, Zeenat
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Zeenat Shyr
Favorite
Siddiqui, Nabil
Memorial Sloan Kettering Cancer Center
(
M1030-01-07
)
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Nabil Siddiqui
Favorite
Singh, Jagdish
North Dakota State University
(
M1430-01-04
)
Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
Jagdish Singh
Favorite
Sodhi, Chhinder
Johns Hopkins University
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Chhinder Sodhi
Favorite
Somaida, Ahmed
Philipps University of Marburg
(
T1430-01-08
)
Sensitization of Paclitaxel-Induced Apoptosis by Echinops giganteus Extract via Downregulation of PI3K/Akt/NF-κB Pathway and Enrichment of TIMP-3 in Cervical Cancer
Ahmed Somaida
Favorite
Song, Qianbo
Chinese University of Hong Kong
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Qianbo Song
Favorite
Souaysene, Amanda
KCAS Bioanalytical & Biomarker
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Amanda Souaysene
Favorite
Spires, Jessica
Simulations Plus, Inc.
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Jessica Spires
Favorite
Srinivasan, Aruna
Syngene International Ltd.
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Aruna Srinivasan
Favorite
Steffen, Ann-Charlott
Gyros Protein Technologies
(
T1030-01-01
)
Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
Ann-Charlott Steffen
Favorite
Stephens, Patricia
Labcorp
(
T1030-01-05
)
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Patricia Stephens
Favorite
Strauch, Bettina
Agilent Technologies Deutschland GmbH
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Bettina Strauch
Favorite
Subramani, Thangamma
Syngene International Ltd.
(
M1430-01-08
)
Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
Thangamma Subramani
Favorite
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Thangamma Subramani
Favorite
Sun, Chengwen
North Dakota State University
(
M1430-01-04
)
Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
Chengwen Sun
Favorite
Sun, Wei
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Wei Sun
Favorite
T
Tabouguia, Megane
IFF
(
M1330-01-03
)
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Megane Tabouguia
Favorite
Tang, Huaping
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Huaping Tang
Favorite
Teller, Callie
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Callie Teller
Favorite
Terry, Frances
EpiVax Inc.
(
M1030-01-04
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Frances Terry
Favorite
(
M1130-01-05
)
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Frances Terry
Favorite
Tong, Anson Hei-Ka
Chinese University of Hong Kong
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Anson Hei-Ka Tong
Favorite
V
Vaidya, SamikshaVishvas
Evonik
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
SamikshaVishvas Vaidya
Favorite
Vamanarao, Nagaraj
Syngene International Ltd.
(
T1430-01-09
)
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Nagaraj Vamanarao
Favorite
Vigil, Brenda
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Brenda Vigil
Favorite
Vo Hoang, Karen
Altasciences
(
T1130-01-07
)
Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Karen Vo Hoang
Favorite
VuTrieu, Isabelle
Waters Corporation
(
T1030-01-02
)
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Isabelle VuTrieu
Favorite
Vyhlidal, Carrie
KCAS Bioanalytical and Biomarker Services
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Carrie Vyhlidal
Favorite
W
Wagner, Erik
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Erik Wagner
Favorite
Wang, Kai
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Kai Wang
Favorite
Wang, Rilla Jiansu
University of Toronto
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Rilla Jiansu Wang
Favorite
Warrino, Dominic
KCAS Bioanalytical & Biomarker
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Dominic Warrino
Favorite
Warzak, Denise
Agilent Technologies, Inc.
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Denise Warzak
Favorite
Waymouth, Robert
Stanford University
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Robert Waymouth
Favorite
Weitz, Dietmar
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Dietmar Weitz
Favorite
Wells, Hannah
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Hannah Wells
Favorite
Wender, Paul
Stanford University
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Paul Wender
Favorite
Wessel, Howard
Noveome Biotherapeutics, Inc.
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Howard Wessel
Favorite
Whitlock, Susan
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Susan Whitlock
Favorite
Woodruff, Mark
Fortis Technologies LImited
(
M1030-01-03
)
Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography
Mark Woodruff
Favorite
Wu, Edward
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Edward Wu
Favorite
Wu, Kangzeng
Zhejiang University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Kangzeng Wu
Favorite
X
Xiao, Yi Qun
NGM Biopharmaceuticals
(
M1430-01-03
)
Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
Yi Qun Xiao
Favorite
Xie, Yuning
Chinese University of Hong Kong
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Yuning Xie
Favorite
Xu, Weifeng
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Weifeng Xu
Favorite
Xu, Xin
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Xin Xu
Favorite
Xu, Yang
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Yang Xu
Favorite
Xu, Yuhong
Zhejiang University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Yuhong Xu
Favorite
Y
Yang, Jihong
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Jihong Yang
Favorite
Yang, Xiao
Chinese University of Hong Kong
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Xiao Yang
Favorite
Yeung, Lai
Bristol-Myers Squibb Company
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Lai Yeung
Favorite
Young, David
Alliance Pharma Inc.
(
M1030-01-08
)
Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
David Young
Favorite
Yun, Tatyana
Merck & Co., Inc.
(
M1130-01-07
)
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Tatyana Yun
Favorite
Yu, Ying Qing
Waters Corporation
(
M1030-01-02
)
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Ying Qing Yu
Favorite
Z
Zaleski, Michael
University of Pennsylvania
(
T1030-01-08
)
Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
Michael Zaleski
Favorite
Zamora, Marco
University of Pennsylvania
(
T1430-01-05
)
Mechanistic Investigation of Side-Effects of Lung Tropic Lipid Nanoparticles
Marco Zamora
Favorite
Zhai, Mengmeng
Alliance Pharma Inc.
(
M1130-01-08
)
Establishment of a Generic ADA Assay for Detection of Anti-Drug Antibody Specific to Human IgG Derived Drug Candidate in Murine Serum Samples
Mengmeng Zhai
Favorite
(
T1130-01-08
)
Labelling AAV5 Capsid Reduced Its Binding Affinity to the Anti-AAV5 Antibody in Non-primate Human Serum Samples
Mengmeng Zhai
Favorite
(
T1430-01-04
)
A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Mengmeng Zhai
Favorite
Zhang, Yufeng
Chinese University of Hong Kong
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Yufeng Zhang
Favorite
Zhao, Jiajia
Chinese University of Hong Kong
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Jiajia Zhao
Favorite
Zhou, Haiying
Simulations Plus, Inc.
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Haiying Zhou
Favorite
Zou, Junju
Chinese University of Hong Kong
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Junju Zou
Favorite
Zughaier, Susu
Qatar University
(
M1130-01-01
)
An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice
Susu Zughaier
Favorite
Zunino, Chiara
Phinc Development
(
T1330-01-06
)
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Chiara Zunino
Favorite
Zuo, Zhong
Chinese University of Hong Kong
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Zhong Zuo
Favorite
(
T1130-01-09
)
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Zhong Zuo
Favorite
Back to Top
